Streeten D H, Anderson G H
Department of Medicine, State University of New York Health Science Center, Syracuse 13210, USA.
Am J Hypertens. 1996 Aug;9(8):760-9. doi: 10.1016/0895-7061(96)00057-x.
We have explored the pathophysiological mechanisms of orthostatic hypotension and orthostatic tachycardia, found to be present in 83% and 61% respectively of 18 patients with subsequently proven pheochromocytoma. Orthostatic increases in plasma norepinephrine (NE) concentrations were significantly greater in the patients than in normal control subjects. Intravenous infusions of NE at 1, 2, 4, 8, and 16 micrograms/min induced similar increases in plasma NE levels but smaller increments in systolic and diastolic BP in the pheochromocytoma patients than in normal control subjects. This was reflected by a significantly greater increment in plasma NE concentration required to raise systolic BP by 15 mm Hg and diastolic BP by 7 mm Hg in the pheochromocytoma patients than in the normal subjects (P < .05 and P < .01, respectively). Measurements of venous contractile responses to locally infused NE by the dorsal hand vein (LVDT) technique revealed significantly reduced slopes of the regressions of log NE infusion rate on change in venous diameter in the pheochromocytoma patients compared with normal subjects. The results indicate reduced responsiveness of the vasculature to NE in patients with pheochromocytoma, probably due to down-regulation of alpha-adrenergic receptors resulting from persistent elevation of the physiological agonist NE. This was shown by other authors to be present in circulating platelets. The pathophysiological importance of the subnormal venous responses to the orthostatic hypotension and tachycardia in the patients were supported by the finding that the orthostatic changes were corrected by lower body compression to 45 mm Hg with a MAST pressure suit.
我们探究了体位性低血压和体位性心动过速的病理生理机制,在18例随后被证实患有嗜铬细胞瘤的患者中,分别有83%和61%存在这两种情况。患者体位性血浆去甲肾上腺素(NE)浓度升高显著高于正常对照受试者。以1、2、4、8和16微克/分钟的速率静脉输注NE,在嗜铬细胞瘤患者中引起的血浆NE水平升高相似,但收缩压和舒张压的升高幅度小于正常对照受试者。这表现为嗜铬细胞瘤患者将收缩压升高15毫米汞柱和舒张压升高7毫米汞柱所需的血浆NE浓度升高幅度显著大于正常受试者(分别为P <.05和P <.01)。通过手背静脉(LVDT)技术测量局部输注NE后的静脉收缩反应,结果显示与正常受试者相比,嗜铬细胞瘤患者中log NE输注速率对静脉直径变化的回归斜率显著降低。结果表明,嗜铬细胞瘤患者的血管系统对NE的反应性降低,这可能是由于生理激动剂NE持续升高导致α-肾上腺素能受体下调所致。其他作者已证实在循环血小板中也存在这种情况。患者对体位性低血压和心动过速的静脉反应异常的病理生理重要性得到了以下发现的支持:通过MAST压力服将下半身压力升至45毫米汞柱可纠正体位性变化。